<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02445014</url>
  </required_header>
  <id_info>
    <org_study_id>2014-P-002058</org_study_id>
    <secondary_id>1R01CA184102-01</secondary_id>
    <nct_id>NCT02445014</nct_id>
  </id_info>
  <brief_title>Pilot Study to Image the Esophagus Using a SECM Tethered Endoscopic Capsule</brief_title>
  <acronym>SECM</acronym>
  <official_title>Pilot Study for Imaging of Barrett's Esophagus Using an Spectrally Encoded Confocal Microscopy Tethered Endoscopic Capsule</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this research is to test the imaging quality of the modified, larger diameter,
      tethered Spectrally Encoded Confocal Microscopy (SECM) capsule in healthy subjects, subjects
      with Barrett's Esophagus (BE), and subjects with Gastroesophageal reflux disease (GERD).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      36 subjects including 12 healthy volunteers, 12 patients with Barrett's Esophagus and 12 with
      Gastroesophageal reflux disease will be enrolled and asked to swallow the SECM HITEC Capsule.
      The subjects will be awake and unsedated.

      The capsule is attached to a string like tether which allows the operator to control as well
      as navigate the capsule as it progresses down the esophagus using natural propulsive force
      called peristalsis.

      As the capsule progresses through the esophagus, multiple images of the esophagus are
      acquired in real time to be analyzed later.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2015</start_date>
  <completion_date type="Actual">June 2017</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Feasibility for Imaging of Esophagus Using an SECM Tethered Endoscopic Capsule.</measure>
    <time_frame>20 minute visit (5-7 minute imaging)</time_frame>
    <description>The number of subjects from whom successful SECM imaging was obtained</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">3</enrollment>
  <condition>Healthy</condition>
  <condition>Barrett's Esophagus</condition>
  <condition>Gastric Acid Reflux</condition>
  <arm_group>
    <arm_group_label>MGH SECM Imaging Capsule</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subject will swallow the SECM imaging capsule and images will be acquired using the SECM Imaging system.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MGH SECM Imaging Capsule</intervention_name>
    <description>Imaging of the Esophagus using the SECM capsule and SECM Imaging system</description>
    <arm_group_label>MGH SECM Imaging Capsule</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects must be 1) a healthy volunteer (18 years or older), or 2) a subject with
             prior diagnosis of BE (18 years or older), or 3) a subject with prior diagnosis of
             GERD (18 years or older).

          -  AND Subject must be able to give informed consent.

          -  AND Subject must eat no solid foods for 8 hours before the procedure and only clear
             liquids for 2 hours before the procedure.

        Exclusion Criteria:

          -  Subjects with any history of or known upper gastrointestinal strictures

          -  OR Subjects with a history of Crohn's disease,

          -  OR Subjects with difficulty swallow
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guillermo J Tearney, MD., PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>April 16, 2015</study_first_submitted>
  <study_first_submitted_qc>May 14, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 15, 2015</study_first_posted>
  <results_first_submitted>March 28, 2019</results_first_submitted>
  <results_first_submitted_qc>July 9, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">July 10, 2019</results_first_posted>
  <last_update_submitted>July 9, 2019</last_update_submitted>
  <last_update_submitted_qc>July 9, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Guillermo Tearney</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Barrett's</keyword>
  <keyword>GERD</keyword>
  <keyword>Capsule</keyword>
  <keyword>SECM</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Barrett Esophagus</mesh_term>
    <mesh_term>Gastroesophageal Reflux</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>In this study we were trying to establish how many participants can provide us with quality imaging using this new technology. Therefore we treated them as one group. 2 healthy subjects and one with BE were enrolled.
Upon reviewing imaging data it was concluded that this new technology is not optimal for the study and the enrollment was stopped.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>MGH SECM Imaging Capsule</title>
          <description>Subject will swallow the SECM imaging capsule and images will be acquired using the SECM Imaging system.
MGH SECM Imaging Capsule: Imaging of the Esophagus using the SECM capsule and SECM Imaging system</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>MGH SECM Imaging Capsule</title>
          <description>Subject will swallow the new large SECM imaging capsule and images will be acquired using the SECM Imaging system.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="3"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Feasibility for Imaging of Esophagus Using an SECM Tethered Endoscopic Capsule.</title>
        <description>The number of subjects from whom successful SECM imaging was obtained</description>
        <time_frame>20 minute visit (5-7 minute imaging)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>MGH SECM Imaging Capsule</title>
            <description>Subject will swallow the SECM imaging capsule and images will be acquired using the SECM Imaging system.
MGH SECM Imaging Capsule: Imaging of the Esophagus using the SECM capsule and SECM Imaging system</description>
          </group>
        </group_list>
        <measure>
          <title>Feasibility for Imaging of Esophagus Using an SECM Tethered Endoscopic Capsule.</title>
          <description>The number of subjects from whom successful SECM imaging was obtained</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>During the procedure and 10 minutes after</time_frame>
      <group_list>
        <group group_id="E1">
          <title>MGH SECM Imaging Capsule</title>
          <description>Subject will swallow the SECM imaging capsule and images will be acquired using the SECM Imaging system. The imaging quality will be reviewed.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Gary Tearney, MD</name_or_title>
      <organization>Mass General Hospital</organization>
      <phone>617-724-2979</phone>
      <email>gtearney@partners.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

